These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD. Whitwell JL; Josephs KA; Avula R; Tosakulwong N; Weigand SD; Senjem ML; Vemuri P; Jones DT; Gunter JL; Baker M; Wszolek ZK; Knopman DS; Rademakers R; Petersen RC; Boeve BF; Jack CR Neurology; 2011 Aug; 77(9):866-74. PubMed ID: 21849646 [TBL] [Abstract][Full Text] [Related]
11. Tau pathology in a family with dementia and a P301L mutation in tau. Mirra SS; Murrell JR; Gearing M; Spillantini MG; Goedert M; Crowther RA; Levey AI; Jones R; Green J; Shoffner JM; Wainer BH; Schmidt ML; Trojanowski JQ; Ghetti B J Neuropathol Exp Neurol; 1999 Apr; 58(4):335-45. PubMed ID: 10218629 [TBL] [Abstract][Full Text] [Related]
12. Selective brain gray matter atrophy associated with APOE ε4 and MAPT H1 in subjects with mild cognitive impairment. Goñi J; Cervantes S; Arrondo G; Lamet I; Pastor P; Pastor MA J Alzheimers Dis; 2013; 33(4):1009-19. PubMed ID: 23064258 [TBL] [Abstract][Full Text] [Related]
14. Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study. Cash DM; Bocchetta M; Thomas DL; Dick KM; van Swieten JC; Borroni B; Galimberti D; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni GB; Laforce R; Finger E; de Mendonça A; Sorbi S; Rossor MN; Ourselin S; Rohrer JD; Neurobiol Aging; 2018 Feb; 62():191-196. PubMed ID: 29172163 [TBL] [Abstract][Full Text] [Related]
15. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Bird TD; Nochlin D; Poorkaj P; Cherrier M; Kaye J; Payami H; Peskind E; Lampe TH; Nemens E; Boyer PJ; Schellenberg GD Brain; 1999 Apr; 122 ( Pt 4)():741-56. PubMed ID: 10219785 [TBL] [Abstract][Full Text] [Related]
16. Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images. Whitwell JL; Boeve BF; Weigand SD; Senjem ML; Gunter JL; Baker MC; DeJesus-Hernandez M; Knopman DS; Wszolek ZK; Petersen RC; Rademakers R; Jack CR; Josephs KA Eur J Neurol; 2015 May; 22(5):745-52. PubMed ID: 25683866 [TBL] [Abstract][Full Text] [Related]
17. Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations. Rosso SM; van Herpen E; Pijnenburg YA; Schoonenboom NS; Scheltens P; Heutink P; van Swieten JC Arch Neurol; 2003 Sep; 60(9):1209-13. PubMed ID: 12975285 [TBL] [Abstract][Full Text] [Related]
18. Phenotypic variation in hereditary frontotemporal dementia with tau mutations. van Swieten JC; Stevens M; Rosso SM; Rizzu P; Joosse M; de Koning I; Kamphorst W; Ravid R; Spillantini MG; Niermeijer ; Heutink P Ann Neurol; 1999 Oct; 46(4):617-26. PubMed ID: 10514099 [TBL] [Abstract][Full Text] [Related]
19. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Rohrer JD; Ridgway GR; Modat M; Ourselin S; Mead S; Fox NC; Rossor MN; Warren JD Neuroimage; 2010 Nov; 53(3):1070-6. PubMed ID: 20045477 [TBL] [Abstract][Full Text] [Related]
20. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]